ABUS - Arbutus Biopharma Corp
IEX Last Trade
3.88
0.050 1.289%
Share volume: 2,485,972
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.83
0.05
1.31%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-09 | 2023-03-02 | 2023-05-04 | 2023-08-03 | 2023-11-07 | 2024-03-05 | 2024-05-02 | |
| Total revenue | 14.241 M | 5.952 M | 6.245 M | 6.687 M | 4.651 M | 4.658 M | 2.145 M | 1.532 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 14.241 M | 5.952 M | 6.245 M | 6.687 M | 4.651 M | 4.658 M | 2.145 M | 1.532 M | |
| -58.21% | 4.92% | 7.08% | -30.45% | 0.15% | -53.95% | -28.58% | |||
| Operating expenses | 28.142 M | 23.548 M | 27.198 M | 23.827 M | 23.672 M | 26.011 M | 22.665 M | 20.715 M | |
| Selling general and admin | 5.200 M | 3.493 M | 4.249 M | 5.552 M | 5.980 M | 5.842 M | 5.101 M | 5.312 M | |
| Research and development | 22.942 M | 20.055 M | 22.949 M | 18.275 M | 17.692 M | 20.169 M | 17.564 M | 15.403 M | |
| Total expenses | 28.142 M | 23.548 M | 27.198 M | 23.827 M | 23.672 M | 26.011 M | 22.665 M | 20.715 M | |
| -16.32% | 15.50% | -12.39% | -0.65% | 9.88% | -12.86% | -8.60% | |||
| Operating income | -13.901 M | -17.596 M | -20.953 M | -17.140 M | -19.021 M | -21.353 M | -20.520 M | -19.183 M | |
| Ebit | -13.901 M | -17.596 M | -20.953 M | -17.140 M | -19.021 M | -21.353 M | -20.520 M | -19.183 M | |
| Pretax income | -14.192 M | -17.567 M | -21.932 M | -16.339 M | -17.094 M | -20.104 M | -19.312 M | -17.875 M | |
| 23.78% | 24.85% | -25.50% | 4.62% | 17.61% | -3.94% | -7.44% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -14.192 M | -17.567 M | -21.932 M | -16.339 M | -17.094 M | -20.104 M | -19.312 M | -17.875 M | |
| -23.78% | -24.85% | 25.50% | -4.62% | -17.61% | 3.94% | 7.44% | |||
| Net income | -14.192 M | -17.567 M | -21.932 M | -16.339 M | -17.094 M | -20.104 M | -19.312 M | -17.875 M | |
| -23.78% | -24.85% | 25.50% | -4.62% | -17.61% | 3.94% | 7.44% |